Sirdalud

Medicinal product

(Invented) name

Sirdalud

Active substance (s)

Tizanidinas

Strength

2 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M03BX02, Tizanidine

Marketing authorisation holder

UAB Ideal Trade Links, Lietuva

Date of authorisation

2023-03-03

Date of renewal

Documents

1845_1846_Sirdalud 2mg_4mg_tab_PZPL_2023-03-03.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Tizanidinas	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
110483	96593	1096593	lizdinė plokštelė	N30		Receptinis	LT/L/23/1845/001	Netiekiama	2025-03-14	2025-03-31	No	-	-	Download
110484	96594	1096594	lizdinė plokštelė	N100		Receptinis	LT/L/23/1845/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-03-03	Registruotas